Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases
Journal of Nuclear Medicine · 2025-12 · 66 (12) · 1970-1975
DOI: 10.2967/jnumed.125.269840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 03.10.2025. Verfasst von David S Goldstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke,…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Lewy Body Disease, Heart, Sympathetic Nervous System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Lewy body diseases (LBDs) feature profound myocardial depletion of the sympathetic neurotransmitter norepinephrine. In addition to sympathetic neuronal loss, the norepinephrine deficiency may reflect decreased vesicular sequestration of cytoplasmic catecholamines in dysfunctional but living nerve terminals. To evaluate intraneuronal vesicular storage in patients with LBDs, we retrospectively analyzed multitracer PET data using 18F-6-fluorodopamine (18F-DA, a sympathetic neuroimaging agent) and 11C-methylreboxetine (11C-MRB, a ligand for the cell membrane norepinephrine transporter). If there were a vesicular storage defect, then the decrease in 18F-DA-derived radioactivity would be greater than the decrease in 11C-MRB-derived radioactivity.
Methods
Twenty-three patients with Parkinson disease or the Lewy body form of pure autonomic failure and 15 controls underwent 18F-DA dynamic scanning (9 frames; last frame, 10-min duration with midpoint at 25 min) and on a separate day underwent 11C-MRB PET for 45 min (dynamic for 30 min, then a static 15-min frame with midpoint at 38 min).
Results
All patients in the LBD group had interventricular septal 18F-DA-derived radioactivity below the range of values in the control group (mean decrease, 75%; P < 0.0001). The LBD group also had a mean decrease of 37% in 11C-MRB-derived radioactivity from the control group in the static frame with midpoint at 38 min (P < 0.0001). At all time points after tracer administration, septal myocardial 18F-DA/11C-MRB ratios were lower in the LBD group (by 68% at 25 min; P < 0.0001).
Conclusion
LBDs entail substantially decreased vesicular storage in cardiac sympathetic nerves. This abnormality has direct implications for disease-modifying treatment and prevention strategies, since extant but dysfunctional ("sick-but-not-dead") neurons may be salvageable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; and goldsteind@nin…
- Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; and.
- Department of Radiology, New York University Langone Medical Center, New York, New York.
Zitieren
APA
Goldstein, D. S., Holmes, C., & Ding, Y. S. (2025). Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases. Journal of Nuclear Medicine, 66(12), 1970-1975. https://doi.org/10.2967/jnumed.125.269840
Vancouver
Goldstein DS, Holmes C, Ding YS. Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases. Journal of Nuclear Medicine. 2025;66(12):1970-1975. doi:10.2967/jnumed.125.269840
BibTeX
@article{Goldstein2025,
author = {Goldstein, David S and Holmes, Courtney and Ding, Yu-Shin},
title = {Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases},
journal = {Journal of Nuclear Medicine},
year = {2025},
volume = {66},
number = {12},
pages = {1970--1975},
doi = {10.2967/jnumed.125.269840}
}
EUVIMED